StockDuty ← Dashboard Oct 30, 2026 05:56 PM ET
SignalCorporate

Iradimed anticipates $25M-$26.5M Q4 revenue as 3870 pump output targets 50%+ sequential growth

Iradimed expects $25M–$26.5M Q4 revenue with 3870 pump output targeting 50%+ sequential growth.

What changed
Iradimed expects $25M–$26.5M Q4 revenue with 3870 pump output targeting 50%+ sequential growth.
Why it matters
Iradimed expects $25M–$26.5M Q4 revenue with 3870 pump output targeting 50%+ sequential growth. — impact context not separately stored; see What changed.
Sources
seekingalpha
Related signals
FITCH AFFIRMS CHINA CREDIT RATING AT 'A' →FITCH ISSUES NEW STATEMENT AND OUTLOOK ON U.S . CREDIT RATING DEBT WARNING IN FIRST PARAGRAPH . →$FMX →